Detailansicht

Ligand mediated carbon nanotubes based delivery of an anticancer agent

ISBN/EAN: 9783330012714
Umbreit-Nr.: 3979551

Sprache: Englisch
Umfang: 136 S.
Format in cm: 0.9 x 22 x 15
Einband: kartoniertes Buch

Erschienen am 12.03.2018
Auflage: 1/2018
€ 55,90
(inklusive MwSt.)
Lieferbar innerhalb 1 - 2 Wochen
  • Zusatztext
    • The greatest impact of nanotechnologies in cancer therapy is in the realm of drug delivery. The therapeutic index of nearly all drugs could be improved if they were more efficiently delivered to their biological targets through appropriate application of nanotechnological tools. An safer and effective cancer drug or drug delivery system should fulfil the following requirements: a) it must have an adequate drug concentration which allows an effective dose at the tumor cells, b) should be targeted to cancer cells, and prevent uptake by normal cells, c) should have a long half-life in blood circulation, d) should have good bio compatibility, and stability which retain the drug until it reach to target. Nanotechnology has the potential to have a revolutionary impact on cancer diagnosis, prevention and therapy.The use of nanotechnology in cancer treatment offers the possibility of destroying cancer cells with minimal damage to healthy tissue and organs. Efficacy and specificity are two basic requirements for cancer therapy. With the advancement of nanotechnology, the application of nano-materials as drug carriers can improve anticancer treatments.
  • Autorenportrait
    • She is a research scholar from Jamia Hamdard, New Delhi, india, Dept. of Pharmaceutics, She has been granted INSPIRE fellowship from DST New Delhi. She has been awarded Gold Medal for being the Best Graduate of Pt. BD Sharma University, Rohtak. She is a member of many professional bodies and published national as well as international papers